All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Adaptimmune Therapeutics plc (ADAP)

Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform.
Add to widgets
Added to widgets
Stock symbol: ADAP
Company name: Adaptimmune Therapeutics plc
Stock exchange: Nasdaq Global Select (NAS)
Category: Healthcare, Biotechnology, Biotechnology
Country: United States
Currency: US dollar (USD)
Website: http://www.adaptimmune.com
CEO: James J. Noble

ADAP is the ticker or stock symbol for Adaptimmune Therapeutics plc. You can trade Adaptimmune Therapeutics plc stocks on NASDAQ stock exchange. Adaptimmune Therapeutics plc is a Healthcare, Biotechnology, Biotechnology company in United States. Stocks of Adaptimmune Therapeutics plc trading in dollars.

Adaptimmune Therapeutics plc is an organization in the stock market, the shares of which are available for purchase and sale by all market participants. The information on Adaptimmune Therapeutics plc shown here is a collection and verified information from reliable online sources. Adaptimmune Therapeutics plc company - or simply Adaptimmune Therapeutics plc - is the name of an officially registered legal entity. Adaptimmune Therapeutics plc assets are listed on the stock market.

Information about the company Adaptimmune Therapeutics plc is provided by the companies themselves, exchanges and other official sources. The information displayed on Adaptimmune Therapeutics plc on this page is collected online from open sources. The ticker of ADAP is the name of the company on the exchange for the unique identification of Adaptimmune Therapeutics plc. A stock ticker is a unique identifier for this company for one exchange.

Adaptimmune Therapeutics plc may also be traded on other exchanges. Typically, the volume of these trades is less than on the main NASDAQ stock exchange. As a rule, the head office of the company is located in this country. Adaptimmune Therapeutics plc is registered in United States today. Information about the country Adaptimmune Therapeutics plc is collected from official sources.

The currency of the company Adaptimmune Therapeutics plc, in which the financial balance of the company is maintained, is US dollar. The currency of a company's financial statements will almost always be the national currency of its country. If the company is international, then the reporting currency of the company is usually the dollar. Diversified companies usually have several official websites.

Web sites of large companies can be faked or copied. It is very important to know the official website of Adaptimmune Therapeutics plc in order to understand that you are working with this organization. The main manager is the official position of the head of the company. Information about the leader of Adaptimmune Therapeutics plc is taken from open sources and tracked online.

Show:
to

Adaptimmune Therapeutics plc stocks data

Adaptimmune Therapeutics plc financials